Chemomab Therapeutics Ltd.

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Their mission is to translate novel biological insights into transformational treatments, driven by evidence and a commitment to improving the quality of life for patients with severe and life-threatening diseases.

Products & Services

Nebokitug (CM-101):A first-in-class dual activity monoclonal antibody that neutralizes CCL24, designed to treat fibrosis-related diseases. It has shown effectiveness in preclinical and clinical studies for liver, skin, and lung fibrosis, with positive data from five clinical trials, including the Phase 2 SPRING trial for primary sclerosing cholangitis (PSC).

Specialties

Fibro-inflammatory diseases Anti-CCL24 therapeutic platform Liver, skin, and lung fibrosis treatments Primary Sclerosing Cholangitis (PSC) Systemic Sclerosis

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2024-07-30 FD: 2024-07-30	3 investors
2	RT: PIPE (Private Investment in Public Equity) T: - FT: PIPE (Private Investment in Public Equity)	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2024-07-25 FD: 2024-07-25	3 investors

Private Placement Latest

2024-07-30

$10.0M

3 investors (Pro only)

PIPE (Private Investment in Public Equity) 2024-07-25

$10.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Kulwiec

Founder and Creative Guy

LinkedIn (Pro only)

N

Nissim Darvish

General Partner at MeOhr Ventures

N

Neil Cohen

Board Director

A

Adi Mor

Co-Founder, Chief Executive Officer and Chief Scientific Officer

A

Alan Moses

Board Director

C

Claude Nicaise

Board Director

View 15 more team members with Pro

Unlock Full Team Directory

Recent News